Cheng-Ta Yang

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Yi‐Long Wu, Ying Cheng, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2020 · 249 citations

Oncology, Met Amplification, Medicine +10

Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center

Chih‐Hung Wang, Ching‐Yi Wu, Cheng-Ta Yang et al. · PLoS ONE · 2016 · 75 citations · Full text

Trends in the utilization of computed tomography and cardiac catheterization among children with congenital heart disease

Cheng-Ta Yang, Ming‐Tai Lin, Fu‐Shan Jaw et al. · Journal of the Formosan Medical Association · 2014 · 38 citations · Full text

Computed Tomography, Cardiac Catheterization, Heart Failure +8

Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients

Steven Shinn‐Forng Peng, Yung‐Ming Jeng, Wen‐Ming Hsu et al. · European Radiology · 2015 · 20 citations

Hepatology, Medical Imaging, Biliary Tract +14

First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial

Qing Zhou, Yan Yu, Ligang Xing et al. · Med · 2024 · 13 citations

Neuro-oncology, Medicine, First-line Zorifertinib +10